Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2014

Mar 4, 2014

29755_dirs_2014-03-04_fffa2206-208a-4e6c-830d-69fce3de0bec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2014-02-28

Reporting Person: SALEKI-GERHARDT AZITA (SVP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-28 Common stock, $0.01 par value F 6336 $51.91 Disposed 88271 Direct
2014-03-03 Common stock, $0.01 par value S 162 $50.24 Disposed 88109 Direct
2014-03-03 Common stock, $0.01 par value S 1200 $50.2460 Disposed 86909 Direct
2014-03-03 Common stock, $0.01 par value S 581 $50.25 Disposed 86328 Direct
2014-03-03 Common stock, $0.01 par value S 100 $50.2530 Disposed 86228 Direct
2014-03-03 Common stock, $0.01 par value S 100 $50.2610 Disposed 86128 Direct
2014-03-03 Common stock, $0.01 par value S 200 $50.2630 Disposed 85928 Direct
2014-03-03 Common stock, $0.01 par value S 100 $50.2640 Disposed 85828 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common stock, $0.01 par value 1700 Indirect
Common stock, $0.01 par value 918 Indirect

Footnotes

F1: Balance in the AbbVie Savings Program as of February 28, 2014.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.